27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Kite Pharma Inc (NASDAQ: KITE) announced positive topline data from the PII ZUMA-1 study in NHL.
“We view the 3-month CR rate across the entire ZUMA-1 cohort as favorable and suggestive of a durable response,” Jefferies’ Biren Amin said in a report. He maintained a Buy rating on the company, with a price target of $72.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
“The ZUMA-1 study pre-defines duration of response as inclusive of all three pt cohorts, and therefore we think the trial should observe a >6 months duration of response which view as a key marker for regulatory approval,” Amin wrote.
Related Link: Juno Therapeutics Viewed As A Sympathy Play On Kite Pharma's KTE-C19
More Information Awaited
The results support the approvability of KTE-C19 and Kite Pharma is likely to offer more details around its commercial aspects during the investor day on October 18. The company would also likely provide a breakdown of the Phase II data by patient subgroup/characteristics during ASH in December.
Durability Of KTE-C19 In NHL
Amin believes that the FDA would be most interested in the durability of response when evaluating the efficacy of KTE-C19 and that Kite Pharma has set a bar of 6.6 months for mOS based on the Scholar 1 study in a similar patient population.
“Although the PII durability data is immature, we view the CR rate at 3 months follow up to be a reasonable proxy for durability at this juncture and believe that most of the CR responses ongoing at 3-months should remain durable,” the analyst wrote.
Shares of Kite Pharma surged more than 8 percent by 10:55 a.m. ET.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.